Quote:
Originally Posted by 77T
You’re right in some quarters if off-label isn’t permitted. Also, choice to enter a trial cohort.
For example, remdesivir, hydroxychloroquine w/plaquenil, favilavir, TJM2, rhSP-D, and others.
The list was long so didn’t know if the PCR test was informative in choosing a route.
|
WHO reports the rate of infection accelerating ...
The patient is deteriorating rapidly ,you going to try the chloroquine or wait for the trial result in a few weeks ? Its obvious